Clinical improvements with Anavex 2-73 (blarcamesine)Â correlated with activation of the SIGMAR1 gene, which provides instructions for making the protein…
Articles by Forest Ray PhD
The nonprofit Rett Syndrome Research Trust (RSRT) and Duke University’s Center for Health Measurement are asking Rett syndrome caregivers to help…
Targeting a biological pathway regulated by MECP2 — the gene mutated in most cases of Rett syndrome — normalized neural…
An independent monitoring board has recommended that all three ongoing clinical trials of Anavex 2-73 (blarcamesine), an investigational treatment for …
People with Rett syndrome can receive the COVID-19 vaccine from Johnson & Johnson and still participate in future clinical…
A $2.1 million grant will fund a study investigating if — and how — cells called astrocytes might affect the…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
Anavex Life Sciences has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO)…
As the Rett Syndrome Research Trust (RSRT) prepares to launch a global database of caregiver-provided information called The…
The National Institute for Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH), awarded nearly…